NCT03979885

Financial Incentives for Smoking Treatment II

Financial Incentives for Smoking Treatment

• Status: Enrolling By Invitation
• Phase: N/A
• Study type: Interventional
• Enrollment: 1,058 (estimated)
• Sponsor: University of California, Los Angeles · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Financial incentives for motivating changes in health behavior, particularly for smoking and other morbid habits, are increasingly being tested by health insurers, employers, and government agencies. However, in using incentive programs for smoking cessation, key unanswered structural and theoretical questions remain regarding their effectiveness, acceptability to patients, and economic sustainability. This trial aims to advance the science and implementation of financial incentives for smoking cessation interventions among high-risk, hospitalized smokers. The investigators will pursue two specific aims: 1) comparing the impact of three approaches for smoking cessation on smoking abstinence, use of evidenced-based therapy, and quality of life and 2) comparing the short-term and long term return on investment of using goal directed and outcome-based financial incentives to promote smoking cessation.

Conditions

• Smoking Cessation
• Tobacco Use Cessation

Interventions

Type	Name	Description
BEHAVIORAL	Smoking cessation counseling (Quitline)	Quitline offers community-based counseling session with a cessation counselor.
BEHAVIORAL	Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy)	Participants will be encouraged to speak to their doctors about using highly effective pharmacotherapies for smoking cessation.
BEHAVIORAL	Financial incentives for smoking cessation	Participants will receive financial incentives for bioconfirmed smoking cessation.
BEHAVIORAL	Financial incentives for use of evidence-based smoking cessation therapies	Participants will receive financial incentives for the use of evidence-based smoking cessation therapies including Quitline counseling, community-based smoking cessation programs and pharmacotherapies

Timeline

• Start date: 2020-01-06
• Primary completion: 2024-12-31
• Completion: 2025-06-30
• First posted: 2019-06-07
• Last updated: 2024-05-02

Locations

2 sites across 1 country: United States